Can lasing at visible wavelengths be achieved using the low-loss long-range surface plasmon-polariton mode?

Copyright © 2006 IOP Publishing Ltd and Deutsche Physikalische Gesellschaft. This is the published version of an article published in New Journal of Physics Vol. 8, article 125. DOI: 10.1088/1367-2630/8/8/125The use of emissive dye molecules as a gain medium in order to excite the low-loss long-range surface plasmon-polariton (SPP) mode on a thin silver film has previously been suggested as a method of achieving SPP lasing at visible wavelengths. Here, we consider the gain lost to the short-range SPP, an aspect that has not been investigated before and which may preclude the possibility of lasing. We show by experiments that gain will indeed be lost to the short-range mode. From a computational study, we find that despite gain lost to the short-range mode, SPP based lasing may still be possible using the long-range mode, although we identify a number of requirements that might make lasing difficult to achieve in practice

Light emission through a corrugated metal film: The role of cross-coupled surface plasmon polaritons

S. Wedge, Ian R. Hooper, I. Sage, and William L. Barnes, Physical Review B, Vol. 69, article 245418 (2004). "Copyright © 2004 by the American Physical Society."We examine the phenomenon of light emission through a thin metal film that takes place via surface plasmon polaritons. Surface plasmon polariton cross coupling has recently been invoked to explain sharp features observed in the angle dependent emission spectra obtained from surface-emitting (through cathode) organic light-emitting diode structures. We investigated whether such a cross-coupling process is needed to explain such observations. We undertook measurements on samples for a variety of metal film thicknesses. Our results are consistent with the mechanism of surface plasmon polariton cross coupling but also show that the processes underlying the emission from such structures can be rather subtle

Coupled surface plasmon-polariton mediated photoluminescence from a top-emitting organic light-emitting structure

Copyright © 2004 American Institute of Physics. This article may be downloaded for personal use only. Any other use requires prior permission of the author and the American Institute of Physics. The following article appeared in Applied Physics Letters 85 (2004) and may be found at http://link.aip.org/link/?APPLAB/85/182/1We report strong photoluminescence from a top-emitting organic light-emitting structure where emission takes place through a thin (55 nm) silver film. We show that this emission is mediated via coupled surface plasmon-polariton modes. Our results show that the addition of a dielectric grating to otherwise planar structures, such as surface-emitting organic light-emitting diodes, may offer a way to increase the external efficiency of top-emitting organic light-emitting diodes

ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model

The effect of ZD1839 (‘Iressa’), a specific inhibitor of the tyrosine kinase activity of the epidermal growth factor receptor, on the radiation response of human tumour cells (LoVo colorectal carcinoma) was evaluated in vitro and in vivo. ZD1839 (0.5 μM, incubated days 1–5) significantly increased the anti-proliferative effect of fractionated radiation treatment (2 Gy day−1, days 1–3) on LoVo cells grown in vitro (P=0.002). ZD1839 combined with either single or fractionated radiotherapy in mice bearing LoVo tumour xenografts, also produced a highly significant increase in tumour growth inhibition (P⩽0.001) when compared to treatment with either modality alone. The radio-potentiating effect of ZD1839 was more apparent when radiation was administered in a fractionated protocol. This phenomenon may be attributed to an anti proliferative effect of ZD1839 on tumour cell re-population between radiotherapy fractions. These data suggest radiotherapy with adjuvant ZD1839 could enhance treatment response. Clinical investigation of ZD1839 in combination with radiotherapy is therefore warranted

A study into the impact of interface roughness development on mechanical degradation of oxides formed on zirconium alloys

AbstractAs a cladding material used to encapsulate nuclear fuel pellets, zirconium alloys are the primary barrier separating the fuel and a pressurised steam or lithiated water environment. Degradation mechanisms such as oxidation can be the limiting factor in the life-time of the fuel assembly. Key to controlling oxidation, and therefore allowing increased burn-up of fuel, is the development of a mechanistic understanding of the corrosion process. In an autoclave, the oxidation kinetics for zirconium alloys are typically cyclical, with periods of accelerated kinetics being observed in steps of ∼2μm oxide growth. These periods of accelerated oxidation are immediately preceded by the development of a layer of lateral cracks near the metal-oxide interface, which may be associated with the development of interface roughness. The present work uses scanning electron microscopy to carry out a statistical analysis of changes in the metal-oxide interface roughness between three different alloys at different stages of autoclave oxidation. The first two alloys are Zircaloy-4 and ZIRLO™ for which analysis is carried out at stages before, during and after first transition. The third alloy is an experimental low tin alloy, which under the same oxidation conditions and during the same time period does not appear to go through transition. Assessment of the metal-oxide interface roughness is primarily carried out based on the root mean square of the interface slope known as the Rdq parameter. Results show clear trends with relation to transition points in the corrosion kinetics. Discussion is given to how this relates to the existing mechanistic understanding of the corrosion process, and the components required for possible future modelling approaches

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer

Medullary thyroid cancer (MTC) represents an aggressive form of thyroid malignancy. Some may occur spontaneously or can be associated with Multiple Endocrine Neoplasia syndromes, or Familial Medullary Thyroid Cancer syndrome. In these patients, the protooncogene RET (rearranged during transfection) is mutated. In patients who have unresectable or metastatic disease, the long term prognosis is poor. New treatments for this disease have focused on the use of targeted agents that inhibit the receptor tyrosine kinase of RET. One of these treatments, Vandetanib (Caprelsa, Astra Zeneca), recently has received approval from the Food and Drug Administration for the treatment of patients with progressive locally advanced and/or metastatic disease. This review highlights the studies that led to the drug’s approval, and discusses on the potential financial costs of treatment and side effects of this therapy. The main clinical studies evaluating Vandetanib for the treatment of other solid tumors will also be reviewed

Surface plasmon-polariton mediated emission from phosphorescent dendrimer light-emitting diodes

Copyright © 2006 American Institute of Physics. This article may be downloaded for personal use only. Any other use requires prior permission of the author and the American Institute of Physics. The following article appeared in Applied Physics Letters 88 (2006) and may be found at http://link.aip.org/link/?APPLAB/88/161105/1We present experimental results showing electroluminescence from a dendrimer based organic light-emitting diode (OLED) mediated via surface plasmon polariton (SPP) modes. A combination of angle dependent electroluminescence, photoluminescence, and reflectance measurements is used to identify emission originating from the guided modes of the device. It is found that the SPP modes, which are usually nonradiative, are coupled to light by a wavelength scale periodic microstructure. It is demonstrated that the necessary microstructure can be readily fabricated by solvent-assisted micromoulding. Our results indicate that such an approach may offer a means to increase the efficiency of dendrimer based OLEDs